Abbott Raises 2026 Profit Outlook After Strong Second Quarter
2026-07-16 11:43:23
Abbott Laboratories raised its 2026 profit guidance after second-quarter sales topped expectations, with improved performance across most of its business lines, according to Bloomberg.
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
Previous article：
Lorenzo Valente：公链已胜过私链
